6
Oct
2026

Cipla Ltd

Exhibitor at CPHI Milan 2026 stand 5F49, Integrated Pharma
About Us

Cipla laid foundations for the Indian pharmaceutical industry back in 1935 with the vision to make India self-reliant in healthcare. Over the years Cipla has emerged as one of the most respected names not just in India but worldwide. Its state of the art R&D centre and manufacturing units has given the country and the world many firsts. Cipla has earned a name for maintaining one global standard for its products and services in over 180 countries. Cipla continues to support, improve and save millions of lives with its high-quality drugs and innovative devices.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
View company profile
Contact info
  • +91 22 2308 2891
  • Website
  • Cipla House Tower C, Peninsula Business Park, Ganapat Rao, Kadam Rd., Lower Parel, 400013, Mumbai, India
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 5F49, Integrated Pharma

Products Featured at CPHI Milan 2026

  • 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml

    Product 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml

    Cipla Ltd offers wide range of veterinary products which includes 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml. Dosage form: injection. Contact us for more information.
  • Abacavir sulfate

    Product Abacavir sulfate

    Cipla Ltd offers wide range of api which includes abacavir sulfate. It belongs to abacavir sulfate category. Contact us for more information.
  • Abacavir sulphate 20 mg/ml

    Product Abacavir sulphate 20 mg/ml

    Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 20 mg/ml. Dosage form: oral solution. Therapeutic area: hiv-aids. Packaging type: bottle. Contact us for more information.
  • Abacavir sulphate 300 mg

    Product Abacavir sulphate 300 mg

    Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 300 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information.
  • Abacavir sulphate 60 mg

    Product Abacavir sulphate 60 mg

    Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 60 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information.